Luminex, Tecan Co-developing Newborn Screening Platform | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex and the Tecan Group today announced a collaboration to develop new automated screening platform for the faster detection of potential health risks in newborns.

The global original equipment manufacturing agreement will combine Luminex's xMAP technology and LX200 instrument with Tecan's Freedom EVO liquid handling platform and HydroFlex Washer.

Terms of the deal were not announced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.